Monthly Archives: November 2016

ASTMH 2016: Infectious disease elimination is a long road

By on .

ATLANTA, Ga – “Elimination has become an enchanted word,” Frank Richards of the Carter Center, said here this morning. He noted the “elimination” of measles in the United States in 2000, in spite of the large numbers of cases that continue to be reported each year. “Follow the metrics when the “e” words — elimination […]

Petition asks BRICS to triple TB R&D funding

By on .

Global tuberculosis treatment advocates and activists are asking leaders of the five countries that are home to almost half of all tuberculosis illnesses and deaths to triple their funding for research and development of new medicines and technologies to prevent, diagnose, and treat the leading infectious disease killer worldwide, on a petition that will be […]

World’s largest Zika database shows most confirmed cases among younger women

By on .

Puerto Rico case distribution consistent with observations in other Zika-infected settings, but not with other impacts of other mosquito-borne viruses, suggesting sexual transmission raises women’s risks Results from nearly a year of testing Puerto Rico residents with suspected Zika illness reported by the U.S. Centers for Disease Prevention and Control today show more than 800 […]

Indicators measure progress towards providing family planning services at HIV clinics

By on .

The following is a guest post by Mary Freyder, MPH of Community Health and Behavioral Health Department, Tulane University School of Public Health and Tropical Medicine The HIV epidemic disproportionately affects women of reproductive age, especially in sub-Saharan Africa, where nearly 60 percent of people living with HIV are women. In support of the global 90-90-90 targets, […]

Global health science, funding, policy and the 2016 election . . . We’re reading some of the reasons the world is watching

By on .

The Lancet: U.S. Election 2016 – While much of this Lancet issue focuses on domestic issues, from the Affordable Care Act to the impacts of economic opportunity on well being, it provides a comprehensive overall look at candidates’ approaches to health and health care access, and includes an article by Washington correspondent Susan Jaffe on […]

White House issues executive order formalizing agency roles in Global Health Security Agenda

By on .

“No single nation can be prepared if other nations remain unprepared to counter biological threats . . .” Executive Order Advancing the Global Health Security Agenda to Achieve a World Safe and Secure from Infectious Disease Threats, Nov. 4, 2016 Guided and monitored by a council of high-level representatives of at least a dozen U.S. […]

IDWeek 2016: Low- and middle-income countries are most affected by antimicrobial resistance, have the least capacity to address it

By on .

NEW ORLEANS, La – Low- and middle income countries have lower per-capita consumption of antibiotics than high income countries yet bear a larger burden of antimicrobial resistance, panelists said at IDWeek. While high-income countries are looking to develop innovative stewardship programs and new drugs to combat antimicrobial resistance, low- and middle-income countries often have limited capacity […]

47th Union World Conference on Lung Health: Soft drink company takes the challenge to build a new Pepsi generation

By on .

LIVERPOOL, England – People have a limited ability to taste sweet things. Cats, it turns out don’t have any. On the other hand, we humans have 22 taste receptors for bitterness. But all of that can be overcome by science. These are some of the things you learn when a company in the business of marketing […]

47th Union World Conference on Lung Health: Projects in Armenia, Georgia, Lesotho and Peru highlight need, promise, obstacles in new drugs

By on .

LIVERPOOL, England – In Lesotho rough terrain and long distances between tuberuculosis patients and health providers challenged rollout of the newest medicines that for many have come to represent both optimal care, and a last resort. In eastern European Georgia, high rates of hepatitis C, and still limited knowledge of drug interactions between the newest anti-TB […]